Researchers examined how a clinical trial on one drug's efficacy affected its use in ambulances across the country.
The team said that the improved adjuvant formulations could reduce side effects.
The study provides the first direct evidence of opiate-related epigenetic alterations in the human brain.
The researchers want to target therapies to distinct "nodes or clusters" of patients based on specific symptoms or molecular features of their disease.
A new class of cholesterol-lowering drug has been found to help patients cut their risk of cardiovascular disease, stroke and heart attack.
The monoclonal antibody is used to treat postmenopausal osteoporosis.
Scientists have identified a key barrier to proliferation of insulin-producing cells, which may lead to new therapies for diabetes patients.
Researchers say that nontoxic amounts of the gas could help prevent coronary artery disease.
Mylan introduced Desvenlafaxine Extended-release Tablets, a generic version of Pfizer's Pristiq Tablets, in the United States.
Biosimilars are highly similar versions of complex biologic therapies.
Antibacterial compounds found in soil could spell the beginning of a new treatment for tuberculosis.
The FDA approved Perrigo’s hydrocodone bitartrate and homatropine methylbromide oral solution.
Aurobindo Pharma acquired four cell culture derived biosimilar products from TL Biopharmaceutical.
Carcinoid syndrome is a cluster of symptoms sometimes seen in people with carcinoid tumors.
ESCMID member Prof. Evelina Tacconelli explains the report’s context and significance.
A team of researchers is working on developing a sustained and controllable insulin-release system.
The discovery could revolutionize drug development and substantially reduce the cost and time drugs need to reach their market.
Two drugs used to treat asthma and allergies may offer a way to prevent a deadly form of pneumonia.
A vital race is on in laboratories across the globe to develop a vaccine for the Zika virus.
More than half of the subjects immunized with three doses of the vaccine were protected 19 weeks after their last dose.
The generic drug approved by the FDA is meant to treat heartworm disease in dogs.
The compound RgIA in the study was obtained from the venom of Conus regius, the royal cone.
An independent study found that the drug had "virtually no chance" of working.
Researchers have come up with a new method that should enable controlled drug delivery into the bloodstream using DNA computers.
The FDA has approved an expanded indication for Boehringer Ingelheim Pharmaceuticals’ Spiriva Respimat (tiotropium bromide).
Mayne Pharma launched Butalbital acetaminophen (APAP) tablets, 50mg/300mg in the United States.
Siliq (brodalumab) treats adults with moderate-to-severe plaque psoriasis.
A new antibiotic, produced by bacteria found on a species of African ant, is very potent against MRSA.
Fresh insights into how immune cells are regulated could signal a new approach to tackling infections.
A magnetic drug implant could offer an alternative for patients struggling with numerous pills or intravenous injections.
Root cause is shared by Alzheimer's and other neurodegenerative diseases.
The drug switches immune cells that turn down the body's attack on tumors back into the kind that amplify it.
Microbes in the gut can disarm antibiotics, leading to antibiotic resistance and incurable infections.
The extract of the Brazilian peppertree's red berries has the power to disarm dangerous antibiotic-resistant staph bacteria.
The study sheds light on the biology of progressive form of multiple sclerosis and suggests a new potential path for treatment.
Teva Pharmaceuticals announced the availability of its Levoleucovorin (Fusilev) generic for injection.
Gastric bypass surgery is one of the most successful treatments for obesity and related disorders.
The antiviral drug oseltamivir can reduce influenza infections and prevent deaths in a cost-saving manner.
Even the tiniest viruses make decisions. Scientists are working on how to leverage these decisions to develop better antibiotics.
A new biologic agent — the most potent of its kind so far — is showing early promise as part of a potential new strategy for treating HIV.
Research in mice could have implications for human brain disease.
An effective and economical treatment for Ebola patients has been developed by an international team of scientists.
The new method gives physicians a better chance at saving lives.
A novel, gene-based investigational vaccine protected mice and monkeys against Zika virus infection after a single dose.
New research findings may lead to the development of new therapies to delay or prevent the development of diabetic retinopathy.
UCLA study has found that an anti-inflammatory medication appears to reduce cravings, improve mood.
Last year, the FDA approved 22 new therapeutic drugs, less than half the number approved in 2015.
Scientists have identified new ways to provide vaccines against polio that do not require the growth of live virus.
OHSU scientists have uncovered a method for quickly and efficiently mapping the genome of single cells within the body.
Scientists have shed new light on how the common painkiller paracetamol causes liver damage.